The PrevAKI multi-centre trial confirmed that after identifying high-risk AKI patients defined as [TIMP-2] × [IGFBP7] ≥ 0.3 (Nephrocheck®), the application of care bundle can reduce the incidence of stage 2 and 3 AKI after cardiac surgery [25]. This evidence concerns the gene TIMP2 and acute kidney injury.